Becton, Dickinson and Co. (BD) is investing in its U.S. manufacturing network to add capacity for critical medical devices, ...

Becton Dickinson plans to invest more than $30M in 2025 to expand its manufacturing capacity for IV lines at its Utah plant.

Becton, Dickinson's stock momentum is improving, but geopolitical risks and global headwinds warrant caution. Click here to ...

Supply chain issues are top of mind at medtech companies since President-elect Donald Trump threatened tariffs on goods from ...

Avery Dennison, in partnership with Turck Vilant Systems & Becton, Dickinson and Company, introduces BD iDFill Individual ...

Becton Dickinson (BDX) announced additional investments in its U.S. manufacturing network to add capacity for medical devices, including ...

Overall, BD is expected to increase its production of domestically manufactured safety-engineered injection devices by more than 40% and conventional syringes by more than 50%. The manufacturer has ...

BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced additional investments in ...